These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 27694690)
1. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death. Shang ZF; Wei Q; Yu L; Huang F; Xiao BB; Wang H; Song M; Wang L; Zhou J; Wang J; Li S Oncotarget; 2016 Sep; 7(38):62340-62351. PubMed ID: 27694690 [TBL] [Abstract][Full Text] [Related]
2. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis. Chen W; Liu Y; Chen H; Ning H; Ding K Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage. Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991 [TBL] [Abstract][Full Text] [Related]
4. Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo. Kwon SJ; Lee SK; Na J; Lee SA; Lee HS; Park JH; Chung JK; Youn H; Kwon J Mol Cancer Ther; 2015 Feb; 14(2):597-607. PubMed ID: 25504753 [TBL] [Abstract][Full Text] [Related]
5. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer. Gong P; Zhang T; He D; Hsieh JT Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235 [TBL] [Abstract][Full Text] [Related]
8. DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4. Jiaranuchart S; Kaida A; Onozato Y; Harada H; Miura M Arch Oral Biol; 2018 Jun; 90():1-8. PubMed ID: 29522917 [TBL] [Abstract][Full Text] [Related]
9. Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo. Zhang T; Zhang L; Zhang T; Fan J; Wu K; Guan Z; Wang X; Li L; Hsieh JT; He D; Guo P Radiat Res; 2014 Jun; 181(6):641-9. PubMed ID: 24844651 [TBL] [Abstract][Full Text] [Related]
10. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. Zeng J; Liu W; Fan YZ; He DL; Li L Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796 [No Abstract] [Full Text] [Related]
11. Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation. Petragnano F; Pietrantoni I; Di Nisio V; Fasciani I; Del Fattore A; Capalbo C; Cheleschi S; Tini P; Orelli S; Codenotti S; Mazzei MA; D'Ermo G; Pannitteri G; Tombolini M; De Cesaris P; Riccioli A; Filippini A; Milazzo L; Vulcano F; Fanzani A; Maggio R; Marampon F; Tombolini V Int J Radiat Biol; 2020 Jun; 96(6):823-835. PubMed ID: 32149569 [No Abstract] [Full Text] [Related]
12. DMAPT inhibits NF-κB activity and increases sensitivity of prostate cancer cells to X-rays in vitro and in tumor xenografts in vivo. Mendonca MS; Turchan WT; Alpuche ME; Watson CN; Estabrook NC; Chin-Sinex H; Shapiro JB; Imasuen-Williams IE; Rangel G; Gilley DP; Huda N; Crooks PA; Shapiro RH Free Radic Biol Med; 2017 Nov; 112():318-326. PubMed ID: 28782644 [TBL] [Abstract][Full Text] [Related]
13. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway. Zhang D; He D; Xue Y; Wang R; Wu K; Xie H; Zeng J; Wang X; Zhau HE; Chung LW; Chang LS; Li L Cancer Res; 2011 Mar; 71(6):2193-202. PubMed ID: 21385902 [TBL] [Abstract][Full Text] [Related]
14. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033 [TBL] [Abstract][Full Text] [Related]
15. Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks. Turney BW; Kerr M; Chitnis MM; Lodhia K; Wang Y; Riedemann J; Rochester M; Protheroe AS; Brewster SF; Macaulay VM Radiother Oncol; 2012 Jun; 103(3):402-9. PubMed ID: 22551565 [TBL] [Abstract][Full Text] [Related]
16. Zerumbone Regulates DNA Repair Responding to Ionizing Radiation and Enhances Radiosensitivity of Human Prostatic Cancer Cells. Chiang PK; Tsai WK; Chen M; Lin WR; Chow YC; Lee CC; Hsu JM; Chen YJ Integr Cancer Ther; 2018 Jun; 17(2):292-298. PubMed ID: 28602099 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation. Zou M; Li Y; Xia S; Chu Q; Xiao X; Qiu H; Chen Y; Zheng Z; Liu F; Zhuang L; Yu S Cell Physiol Biochem; 2017; 44(2):778-791. PubMed ID: 29169152 [TBL] [Abstract][Full Text] [Related]
18. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair. Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142 [No Abstract] [Full Text] [Related]
19. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752 [TBL] [Abstract][Full Text] [Related]
20. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Wang R; Xu J; Saramäki O; Visakorpi T; Sutherland WM; Zhou J; Sen B; Lim SD; Mabjeesh N; Amin M; Dong JT; Petros JA; Nelson PS; Marshall FF; Zhau HE; Chung LW Cancer Res; 2004 Mar; 64(5):1589-94. PubMed ID: 14996714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]